James K. Hammitt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
James K. Hammitt has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Charlene Gay
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, Boston, MA 02215, USA
1 shared publication - Douglas W. Dockery
Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA
1 shared publication - Grace M. Lee
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
1 shared publication Jin-Tan Liu
National Taiwan University
1 shared publication- John S. Evans
Environmental Health Department, Harvard T.H. Chan School of Public Health, Boston, MA, USA
1 shared publication - Joshua A. Salomon
Department of Health Policy, Stanford University School of Medicine , Stanford, California
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Health Economics
- Vol. 75, 102412
Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime
- 1 January 2021
- Published by Elsevier in Journal of Health Economics
- Vol. 75, 102412
Open AccessFair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime
- Open Access
- 24 December 2020
- Published by Wiley in Risk Analysis
- Vol. 41 (4) , 661-677
Mortality Benefits and Control Costs of Improving Air Quality in Mexico City: The Case of Heavy Duty Diesel Vehicles
Diesel vehicles are significant contributors to air pollution in Mexico City. We estimate the costs and mortality benefits of retrofitting heavy‐duty vehicles with particulate filters and oxidation catalysts. The feasibility and cost‐effectiveness of controls differ by vehicle model‐year and type. We evaluate 1985 to 2014 model‐year vehicles from 10 vehicle classes and five model‐year groups. Our analysis shows that retrofitting all vehicles with the control that maximizes expected net benefits for that vehicle type and model‐year group has the potential to reduce emissions of primary fine particles (PM2.5) by 950 metric tons/year; cut the population‐weighted annual mean concentration of PM2.5 in Mexico City by 0.90 µg/m3; reduce the annual number of deaths attributable to air pollution by over 80; and generate expected annual health benefits of close to 250 million US$. These benefits outweigh expected costs of 92 million US$ per year. Diesel retrofits are but one step that should viewed in the context of other efforts––such as development of an integrated public transportation system, promotion of the rational use of cars, reduction of emissions from industrial sources and fires, and redesign of the Mexico City Metropolitan Area to reduce urban sprawl––that must be analyzed and implemented to substantially control air pollution and protect public health. Even if considering other potential public health interventions, which would offer greater benefits at the same or lower costs, only by conducting, promoting, and publishing this sort of analyses, we can make strides to improve public health cost‐effectively.
- 24 December 2020
- Published by Wiley in Risk Analysis
- Vol. 41 (4) , 661-677
Open AccessMortality Benefits and Control Costs of Improving Air Quality in Mexico City: The Case of Heavy Duty Diesel Vehicles
Diesel vehicles are significant contributors to air pollution in Mexico City. We estimate the costs and mortality benefits of retrofitting heavy‐duty vehicles with particulate filters and oxidation catalysts. The feasibility and cost‐effectiveness of controls differ by vehicle model‐year and type. We evaluate 1985 to 2014 model‐year vehicles from 10 vehicle classes and five model‐year groups. Our analysis shows that retrofitting all vehicles with the control that maximizes expected net benefits for that vehicle type and model‐year group has the potential to reduce emissions of primary fine particles (PM2.5) by 950 metric tons/year; cut the population‐weighted annual mean concentration of PM2.5 in Mexico City by 0.90 µg/m3; reduce the annual number of deaths attributable to air pollution by over 80; and generate expected annual health benefits of close to 250 million US$. These benefits outweigh expected costs of 92 million US$ per year. Diesel retrofits are but one step that should viewed in the context of other efforts––such as development of an integrated public transportation system, promotion of the rational use of cars, reduction of emissions from industrial sources and fires, and redesign of the Mexico City Metropolitan Area to reduce urban sprawl––that must be analyzed and implemented to substantially control air pollution and protect public health. Even if considering other potential public health interventions, which would offer greater benefits at the same or lower costs, only by conducting, promoting, and publishing this sort of analyses, we can make strides to improve public health cost‐effectively.
- Open Access
- 1 January 2010
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 8 (1) , 28
Preferences for health outcomes associated with Group A Streptococcal disease and vaccination
A 26-valent Group A Streptococcus (GAS) vaccine candidate has been developed that may provide protection against pharyngitis, invasive disease and rheumatic fever. However, recommendations for the use of a new vaccine must be informed by a range of considerations, including parents' preferences for different relevant health outcomes. Our objectives were to: (1) describe parent preferences for GAS disease and vaccination using willingness-to-pay (WTP) and time trade-off (TTO) methods; and (2) understand how parents' implied WTP for a quality-adjusted life year (QALY) gained might vary depending on the particular health outcome considered (e.g. averted GAS disease vs. vaccine adverse events).
- 1 January 2010
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 8 (1) , 28
Open AccessPreferences for health outcomes associated with Group A Streptococcal disease and vaccination
A 26-valent Group A Streptococcus (GAS) vaccine candidate has been developed that may provide protection against pharyngitis, invasive disease and rheumatic fever. However, recommendations for the use of a new vaccine must be informed by a range of considerations, including parents' preferences for different relevant health outcomes. Our objectives were to: (1) describe parent preferences for GAS disease and vaccination using willingness-to-pay (WTP) and time trade-off (TTO) methods; and (2) understand how parents' implied WTP for a quality-adjusted life year (QALY) gained might vary depending on the particular health outcome considered (e.g. averted GAS disease vs. vaccine adverse events).
- 1 June 2004
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 23 (6) , 303-305
Economic implications of hormesis: response to commentators
- 1 June 2004
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 23 (6) , 303-305
Economic implications of hormesis: response to commentators
- 31 January 2004
- Published by Elsevier in Journal of Environmental Economics and Management
- Vol. 47 (1) , 13-29
Does risk aversion increase the value of mortality risk?
- 31 January 2004
- Published by Elsevier in Journal of Environmental Economics and Management
- Vol. 47 (1) , 13-29
Does risk aversion increase the value of mortality risk?
- 1 January 2004
- Published by Springer Nature in Journal of Risk and Uncertainty
- Vol. 28 (1) , 73-95
Effects of Disease Type and Latency on the Value of Mortality Risk
- 1 January 2004
- Published by Springer Nature in Journal of Risk and Uncertainty
- Vol. 28 (1) , 73-95
Effects of Disease Type and Latency on the Value of Mortality Risk
- 1 October 2002
- Published by Wiley in Risk Analysis
- Vol. 22 (5) , 985-1001
QALYs Versus WTP
Quality adjusted life years (QALYs) and willingness to pay (WTP) are alternative measures of the value of reductions in health risk that are often used in evaluating environmental, health, and safety practices. Although both methods are based on individual preferences, the underlying assumptions differ. The different bases yield systematically different conclusions about the relative value of reducing health and mortality risks to individuals that differ in age, preexisting health conditions, income, and other factors. The choice of which method to use depends on judgments about what constraints should be placed on individual preferences and what factors should be considered in aggregating preferences across people.
- 1 October 2002
- Published by Wiley in Risk Analysis
- Vol. 22 (5) , 985-1001
QALYs Versus WTP
Quality adjusted life years (QALYs) and willingness to pay (WTP) are alternative measures of the value of reductions in health risk that are often used in evaluating environmental, health, and safety practices. Although both methods are based on individual preferences, the underlying assumptions differ. The different bases yield systematically different conclusions about the relative value of reducing health and mortality risks to individuals that differ in age, preexisting health conditions, income, and other factors. The choice of which method to use depends on judgments about what constraints should be placed on individual preferences and what factors should be considered in aggregating preferences across people.